Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1987 1
1990 1
1991 2
1992 2
1993 3
1994 3
1995 2
1996 9
1997 4
1998 7
1999 12
2000 5
2001 4
2002 3
2003 5
2004 9
2005 10
2006 11
2007 11
2008 7
2009 6
2010 7
2011 11
2012 12
2013 6
2014 8
2015 7
2016 6
2017 7
2018 6
2019 6
2020 3
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

183 results
Results by year
Filters applied: . Clear all
Page 1
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M; EURAMOS collaborators. Whelan JS, et al. Among authors: bohling t. Ann Oncol. 2015 Feb;26(2):407-14. doi: 10.1093/annonc/mdu526. Epub 2014 Nov 24. Ann Oncol. 2015. PMID: 25421877 Free PMC article. Clinical Trial.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. Among authors: bohling t. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Post-transplant Merkel Cell Carcinoma.
Koljonen V, Sahi H, Böhling T, Mäkisalo H. Koljonen V, et al. Among authors: bohling t. Acta Derm Venereol. 2016 May;96(4):442-7. doi: 10.2340/00015555-2284. Acta Derm Venereol. 2016. PMID: 26554531 Free article. Review.
Malignant Eccrine Porocarcinoma in Finland During 2007 to 2017.
Meriläinen AS, Pukkala E, Böhling T, Koljonen V. Meriläinen AS, et al. Among authors: bohling t. Acta Derm Venereol. 2021 Jan 5;101(1):adv00363. doi: 10.2340/00015555-3718. Acta Derm Venereol. 2021. PMID: 33313937 Free article.
Craniomaxillofacial osteosarcoma - The role of surgical margins.
Kontio R, Hagström J, Lindholm P, Böhling T, Sampo M, Mesimäki K, Saarilahti K, Koivunen P, Mäkitie AA. Kontio R, et al. Among authors: bohling t. J Craniomaxillofac Surg. 2019 Jun;47(6):922-925. doi: 10.1016/j.jcms.2019.03.020. Epub 2019 Mar 25. J Craniomaxillofac Surg. 2019. PMID: 31005379
Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
Smeland S, Wiebe T, Böhling T, Brosjö O, Jonsson K, Alvegård TA. Smeland S, et al. Among authors: bohling t. Acta Orthop Scand Suppl. 2004 Apr;75(311):92-8. doi: 10.1080/00016470410001708380. Acta Orthop Scand Suppl. 2004. PMID: 15188671 Review. No abstract available.
183 results